Fresolimumab (Anti-TGFb1)
Fresolimumab (Anti-TGFb1) (A2336-GRP)
Products
Description
Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2336 |
| Target | TGF-beta/Smad |